ATE417035T1 - Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen - Google Patents

Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen

Info

Publication number
ATE417035T1
ATE417035T1 AT05806455T AT05806455T ATE417035T1 AT E417035 T1 ATE417035 T1 AT E417035T1 AT 05806455 T AT05806455 T AT 05806455T AT 05806455 T AT05806455 T AT 05806455T AT E417035 T1 ATE417035 T1 AT E417035T1
Authority
AT
Austria
Prior art keywords
analogues
prevention
treatment
vitamin
bone diseases
Prior art date
Application number
AT05806455T
Other languages
English (en)
Inventor
Roger Bouillon
Annemieke Verstuyf
Clercq Pierre De
Maurits Vandewalle
Original Assignee
Leuven K U Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven K U Res & Dev filed Critical Leuven K U Res & Dev
Application granted granted Critical
Publication of ATE417035T1 publication Critical patent/ATE417035T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05806455T 2004-10-15 2005-10-17 Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen ATE417035T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0422929.0A GB0422929D0 (en) 2004-10-15 2004-10-15 Bioactive vitamin D analogues

Publications (1)

Publication Number Publication Date
ATE417035T1 true ATE417035T1 (de) 2008-12-15

Family

ID=33462778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05806455T ATE417035T1 (de) 2004-10-15 2005-10-17 Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen

Country Status (6)

Country Link
US (2) US7704986B2 (de)
EP (1) EP1809599B8 (de)
AT (1) ATE417035T1 (de)
DE (1) DE602005011661D1 (de)
GB (1) GB0422929D0 (de)
WO (1) WO2006039763A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060884A1 (en) * 2004-12-06 2006-06-15 K.U. Leuven Research & Development 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes
WO2013105026A1 (en) 2012-01-09 2013-07-18 Department Of Biotechnology (Dbt) A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
ES2536256B2 (es) * 2013-11-20 2016-02-01 Universidade De Santiago De Compostela Análogos de vitamina d con interés farmacéutico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
AU699200B2 (en) 1993-07-09 1998-11-26 Roger Bouillon Novel structural analogues of vitamin D

Also Published As

Publication number Publication date
EP1809599B8 (de) 2012-04-04
US20080032955A1 (en) 2008-02-07
US8258126B2 (en) 2012-09-04
WO2006039763A1 (en) 2006-04-20
US20100160455A1 (en) 2010-06-24
EP1809599A1 (de) 2007-07-25
US7704986B2 (en) 2010-04-27
DE602005011661D1 (de) 2009-01-22
EP1809599B1 (de) 2008-12-10
GB0422929D0 (en) 2004-11-17
WO2006039763A8 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
EP1851237A4 (de) Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
EA201690265A3 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EP1809280A4 (de) Mitotische kinesinhemmer und verfahren zu ihrer verwendung
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
IL185391A0 (en) Quinazolinone t-type calcium channel antagonists
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
ATE329587T1 (de) Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen
TW200612892A (en) Novel compounds
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
TNSN07161A1 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DE60317061D1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
MX2009003981A (es) Agentes moduladores del receptor de calcio.
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
SG161310A1 (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE60233261D1 (de) Inhibitoren von humanem adam-10
DK1768748T3 (da) Sammensætninger omfattende strontium og vitamin D samt anvendelser deraf
BRPI0514111B8 (pt) derivados de benzamidina, processo para a preparação destes e composição farmacêutica compreendendo os mesmos
AU2003251728A8 (en) Placental growth factor as a target for the treatment of osteoporosis
DE602005011661D1 (de) Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties